Numerous classes of general anesthetics inhibit etomidate binding to gamma-aminobutyric acid type A (GABAA) receptors.
Enhancement of gamma-aminobutyric acid type A receptor (GABA(A)R)-mediated inhibition is a property of most general anesthetics and a candidate for a molecular mechanism of anesthesia. Intravenous anesthetics, including etomidate, propofol, barbiturates, and neuroactive steroids, as well as volatile anesthetics and long-chain alcohols, all enhance GABA(A)R function at anesthetic concentrations. The implied existence of a receptor site for anesthetics on the GABA(A)R protein was supported by identification, using photoaffinity labeling, of a binding site for etomidate within the GABA(A)R transmembrane domain at the beta-alpha subunit interface; the etomidate analog [(3)H]azietomidate photolabeled in a pharmacologically specific manner two amino acids, alpha1Met-236 in the M1 helix and betaMet-286 in the M3 helix (Li, G. D., Chiara, D. C., Sawyer, G. W., Husain, S. S., Olsen, R. W., and Cohen, J. B. (2006) J. Neurosci. 26, 11599-11605). Here, we use [(3)H]azietomidate photolabeling of bovine brain GABA(A)Rs to determine whether other structural classes of anesthetics interact with the etomidate binding site. Photolabeling was inhibited by anesthetic concentrations of propofol, barbiturates, and the volatile agent isoflurane, at low millimolar concentrations, but not by octanol or ethanol. Inhibition by barbiturates, which was pharmacologically specific and stereospecific, and by propofol was only partial, consistent with allosteric interactions, whereas isoflurane inhibition was nearly complete, apparently competitive. Protein sequencing showed that propofol inhibited to the same extent the photolabeling of alpha1Met-236 and betaMet-286. These results indicate that several classes of general anesthetics modulate etomidate binding to the GABA(A)R: isoflurane binds directly to the site with millimolar affinity, whereas propofol and barbiturates inhibit binding but do not bind in a mutually exclusive manner with etomidate.
Li
Guo-Dong
GD
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, USA. guodongli@mednet.ucla.edu
Chiara
David C
DC
Cohen
Jonathan B
JB
Olsen
Richard W
RW
D000495:Allosteric Site; D018681:Anesthetics, General; D000818:Animals; D001463:Barbiturates / Q000494:pharmacology; D001665:Binding Sites; D002417:Cattle; D004305:Dose-Response Relationship, Drug; D000431:Ethanol / Q000494:pharmacology; D005045:Etomidate / Q000494:pharmacology*; D006801:Humans; D007530:Isoflurane / Q000494:pharmacology; D000442:Octanols / Q000494:pharmacology; D015742:Propofol / Q000494:pharmacology; D011485:Protein Binding; D011963:Receptors, GABA-A / Q000737:chemistry*
D018681:Anesthetics, General; D001463:Barbiturates; D000442:Octanols; D011963:Receptors, GABA-A; D000431:Ethanol; D007530:Isoflurane; D015742:Propofol; D005045:Etomidate